Revenue (Tables)

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
Biologics	40 %	32 %	40 %	29 %
Generics	18 %	18 %	17 %	19 %
Pharma	24 %	27 %	24 %	28 %
Contract-Manufactured Products	18 %	23 %	19 %	24 %
	100 %	100 %	100 %	100 %

The following table presents the approximate percentage of our net sales by product category:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
High-Value Product Components	55 %	47 %	54 %	45 %
High-Value Product Delivery Devices	5 %	5 %	4 %	5 %
Standard Packaging	22 %	25 %	23 %	26 %
Contract-Manufactured Products	18 %	23 %	19 %	24 %
	100 %	100 %	100 %	100 %

The following table presents the approximate percentage of our net sales by geographic location:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
Americas	45 %	49 %	45 %	49 %
Europe, Middle East, Africa	45 %	42 %	45 %	43 %
Asia Pacific	10 %	9 %	10 %	8 %
	100 %	100 %	100 %	100 %

Schedule of Change in Contract with Customer, Asset and Liability

The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2020	$	10.9
Contract assets, September 30, 2021	12.8
Change in contract assets - increase (decrease)	$	1.9
Deferred income, December 31, 2020	$	(57.1)
Deferred income, September 30, 2021	(38.1)
Change in deferred income - decrease (increase)	$	19.0